secwatch.observer — SEC 8-K summary
======================================

Issuer:     NOVANTA INC (NOVT)
CIK:        0001076930
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001193125-25-303940
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Novanta appoints Alexander Manganiello as General Counsel and Corporate Secretary
--------------------------------------------------------------------------------

- Appointed Alexander Manganiello as General Counsel and Corporate Secretary effective December 1, 2025.
- Prior role: VP, Deputy General Counsel at Vertex Pharmaceuticals (2019-2025).
- Previously held senior legal roles at Pfizer Inc. (2004-2019) and practiced at Ropes & Gray.
- Holds A.B. Biology from Harvard University and J.D. from Suffolk Law School.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1076930/000119312525303940/0001193125-25-303940-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1076930/000119312525303940/novt-20251201.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-303940

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer